Overview

Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine how best to treat adolescents with depression that is "resistant" to the first SSRI antidepressant they have tried. Participants receive one of three other antidepressant medications, either alone or in combination with cognitive behavioral therapy.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Antidepressive Agents
Citalopram
Fluoxetine
Venlafaxine Hydrochloride